The Oncosearch | Oncotarget

Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer? Editorial

Thomas Zilli, Piet Ost

Published Sep 17, 2018 · Vol. 9, No. 76 · pp. 34196-34197

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment Research Paper

Concetta Elisa Onesti, Claire Josse, AurÃ©lie Poncin, Pierre FrÃ¨res, Christophe Poulet, Vincent Bours, Guy Jerusalem

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33719-33733

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Francesca De Felice, Giancarlo Dâ€™Ambrosio, Daniela Musio, Franco Iafrate, Ilaria Benevento, Marco Marzo, Marialaura Mancini, Federica Urbano, Marcella Iannitti, Francesco Marampon, Nadia Bulzonetti, Enrico Cortesi, Vincenzo Tombolini

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33702-33709

Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen Research Paper

Joshua N. Kellner, Eric Yvon, Simrit Parmar

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33694-33701

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review Research Paper

Karim Hafazalla, Arjun Sahgal, Blessing Jaja, James R. Perry, Sunit Das

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33623-33633

Modulation of genomic and epigenetic end-points by celecoxib Research Paper

Alberto Izzotti, Sebastiano La Maestra, Rosanna T. Micale, Alessandra Pulliero, Marta Geretto, Roumen Balansky, Silvio De Flora

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33656-33681

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells Research Paper

Uri Rozovski, David M. Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan Burger, Phillip Thompson, Nitin Jain, William Wierda, Michael J. Keating, Zeev Estrov

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33710-33718

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma Research Paper

Amy M. Buckley, Niamh Lynam-Lennon, Susan A. Kennedy, Margaret R. Dunne, John J. Aird, Emma K. Foley, Niamh Clarke, Narayanasamy Ravi, Dermot Oâ€™Toole, John V. Reynolds, BreandÃ¡n N. Kennedy, Jacintha Oâ€™Sullivan

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33634-33647

Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline Research Paper

Aldo Germani, Fabio Libi, Stefano Maggi, Gianluca Stanzani, Augusto Lombardi, Patrizia Pellegrini, Mauro Mattei, Laura De Marchis, Claudio Amanti, Antonio Pizzuti, Maria Rosaria Torrisi, Maria Piane

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33648-33655

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Clinton Yam, Mien-Chie Hung, Gabriel N. Hortobagyi

Published Sep 13, 2018 · Vol. 9, No. 76 · pp. 34193-34195

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction? Editorial

Amelia McCartney, Angelo Di Leo, Luca Malorni

Published Sep 13, 2018 · Vol. 9, No. 75 · pp. 34031-34032

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer Research Paper

Michael J.G. Milevskiy, Gurveen K. Sandhu, Anna Wronski, Darren Korbie, Brooke L. Brewster, Annette Shewan, Stacey L. Edwards, Juliet D. French, Melissa A. Brown

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33577-33588

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, Anindita Chakrabarty

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33589-33600

The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma Research Paper

Hisham F. Bahmad, Tarek H. Mouhieddine, Reda M. Chalhoub, Sahar Assi, Tarek Araji, Farah Chamaa, Muhieddine M. Itani, Amaly Nokkari, Firas Kobeissy, Georges Daoud, Wassim Abou-Kheir

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33549-33561

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer Research Paper

Mohamad Elbaz, Dinesh Ahirwar, Zhang Xiaoli, Xinyu Zhou, Maryam Lustberg, Mohd W. Nasser, Konstantin Shilo, Ramesh K. Ganju

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33459-33470

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines Research Paper

Moses Koobotse, Jeff Holly, Claire Perks

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33562-33576

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, Shu-Hui Liu

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33446-33458

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk Research Paper

Masashi Muramatsu, Shin Akakura, Lingqiu Gao, Jennifer Peresie, Benjamin Balderman, Irwin H. Gelman

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33515-33527

Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma Research Paper

David Dunkin, Alina C. Iuga, Sanda Mimouna, Carolyn L. Harris, Jean-Vianney Haure-Mirande, Dominique Bozec, Garabet Yeretssian, Stephanie Dahan

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33536-33548

Itâ€™s a numbers gameâ€”density-dependent MMP activity mediates cancer cell migration News

Jude M. Phillip, Nahuel Zamponi, Madonna P. Phillip

Published Sep 7, 2018 · Vol. 9, No. 74 · pp. 33867-33868

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer? Editorial

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment Research Paper

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen Research Paper

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review Research Paper

Modulation of genomic and epigenetic end-points by celecoxib Research Paper

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells Research Paper

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma Research Paper

Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline Research Paper

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction? Editorial

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma Research Paper

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer Research Paper

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines Research Paper

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk Research Paper

Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma Research Paper

Itâ€™s a numbers gameâ€”density-dependent MMP activity mediates cancer cell migration News

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer? Editorial

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment Research Paper

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen Research Paper

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review Research Paper

Modulation of genomic and epigenetic end-points by celecoxib Research Paper

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells Research Paper

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma Research Paper

Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline Research Paper

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction? Editorial

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma Research Paper

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer Research Paper

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines Research Paper

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk Research Paper

Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma Research Paper

Itâ€™s a numbers gameâ€”density-dependent MMP activity mediates cancer cell migration News